Widecells Share Discussion Threads

[timbo003] 01/5/2018 14:22

I wonder if the BOD are beginning to question their own wisdom of floating on the main market rather then AIM. There is quite a bit of soft EIS and VCT money currently floating around looking for a home. AIM companies are eligble for EIS/VCT investment, main listing companies are not.

[euclid5] 01/5/2018 13:23

Many options to select from........they would of made an executive decision months ago, & not left it to the 11th hour

[longshanks] 01/5/2018 13:09

The issue is that they have no cash other than through directors loans and have left it to the last minute before notifying the market.The FY results remain unaudited, and if they were would provide a conclusion that the company is insolvent.The board does have experience but it seems that they are not fit to run a PLC: the non-execs have a lot to answer for here. I would say 70-80% chance of being suspended within weeks and 50-70% risk of delisting. Too risky for me - I'm out.

[zen12] 01/5/2018 12:06

Unless they have many options to select from and negotiating the best one!

[euclid5] 01/5/2018 11:54

They may be experienced but will they dig into their pockets to subcribe to the placing?

Last broker note n Nov 2017 mentioned a capital raising, so 5 months ago. Are the city that confident in their business? Doesn't take 5 months to complete a placing!

[zen12] 01/5/2018 11:22

Very experienced BOD here, so confident they’ll see this through. As per rns funding discussions still ongoing, just market overreaction

[euclid5] 01/5/2018 10:22

All well & good telling us about the corporate update in late Dec 2017, but they forgot to let us know they need a capital raise.

With all the new appointed directors with huge experience & excellent backgrounds, I wonder why they don't dig into their pocket to help with fundraising.

___ _)____________________________________________________________

WideCells Group CEO, João Andrade, said, "Having listed WideCells Group in July 2016 we have delivered on our ambition to create an end-to-end stem cell service that transforms the way the industry as a whole operates by making access to treatment affordable and unrestrained by geography. With three divisions now operational and starting to generate revenues, we are about to embark on a new period of growth and development as we look to build our operational reach on an international scale, increase our client base, and ultimately transform the value profile of our company. To achieve this, we are delighted to have completed several planned corporate changes to ensure we are best positioned for growth.



"We have welcomed three new board members, who bring a wealth of corporate knowledge and experience in the insurance, medical and financial industries, which will be invaluable to us as we target new markets and seek new commercial agreements to facilitate the roll-out of our stem cell services. To support this new Board, and in line with our commitment to maintaining operational excellence and being at the fore of our field, we have also created a new Scientific Advisory Committee, which brings together some of the best brains in stem cell technology and regenerative medicine. The committee's unrivalled knowledge and prestigious network of contacts will I believe provide us with a number of exciting growth opportunities.

[longshanks] 01/5/2018 08:34

"The Group has been in discussion with its financial advisers with a view to a fundraising, in the absence of which the Group is at risk of not being able to continue trading as a going concern"Words like that are not encouraging. Strong likelihood of delisting in due course IMO. The amount of cash they need would dilute the hell out of this.

[longshanks] 01/5/2018 08:26

Fair if they can raise cash. If they go bust though....

[imjustdandy] 01/5/2018 08:24

Fair value down here at 5

[longshanks] 01/5/2018 08:00

I anticipate nearer 80% will be wiped off

[euclid5] 01/5/2018 07:52

Amazing, how they have all these fancy videos, telling us about the multi billion $ market they are involved in stem cell's etc & now look, no YE accounts & no placing, as yet - guess 50% will get knocked off today

If the BoD's are that skilled & experienced, why don't they self fund the company

__ ____________________________________________________________

WideCells Group PLC, the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, announces that the publication of the Group's annual financial statements for the period ended 31 December 2017 has been delayed pending completion of the audit process. The requirement of Disclosure Guidance and Transparency Rule (DTR) 4.1.3 is that WideCells Group's annual accounts must be published no later than four months after the end of the accounting period to which they relate. Publication of the 2017 Accounts will be later than the required publication date of Monday 30 April 2018.



The Group has been in discussion with its financial advisers with a view to a fundraising, in the absence of which the Group is at risk of not being able to continue trading as a going concern. These discussions, which have involved negotiations with the Group's banks and financial advisers over the possibility of a placement of shares, have taken longer than originally anticipated. This has resulted in the delay of the audit process. The Group will update the market in due course.



Additionally, the Group wishes to announce that it has accepted loans from certain directors during April 2018 of approximately £115,000 in addition to a loan of £100,000 accepted in October 2017.

[euclid5] 27/4/2018 21:51

Broker note by Capital Network in 30 Nov 17 mentioned at the end about capital raising - so that's why shares have been drifting lower recently

There YE 31/12 2017 accounts should of been released also by March / April 18, may contact their Broker monday & ask when they are due

[longshanks] 25/4/2018 12:04

Where is the support...price is drifting ever downwards The company seems a little slow in issuing results too so difficult to assess what is what.I still like the company and am tempted to buy more shares: just really pleased I didn't get too many at 14p.

[rampair] 21/3/2018 08:19

Longshanks that saved me posting that as I agree entirely!
João Andrade the CEO has done amazing
things with his little company and clearly
runs it like it’s a multinational considering the Board quality. I think
this deserves to succeed

[longshanks] 21/3/2018 07:43

No idea, but I am sure the company would happily discuss it with you if you have some professional insight.The company has some rather astonishing projections as to its anticipated growth in revenues: clearly ambitious, with some high profile board members, this is still very much a micro-cap company though. Furthermore it is one with a full listing and not a "shady AIM" one.It is too early to know if this is a company that will succeed. However there has been growing interest in stem cell research and application: only this week there has been a story of a man in his 80's who's macular degeneration in his right eye was halted and reversed by a stem cell implant.I have some shares as I think this could see explosive growth at some point. I haven't bought many because I suspect we are still some time away from a clear revenue stream.

[237gmoney] 20/3/2018 14:46

Hi All, I'm new here. Can anyone tell me who the Reinsurance partners are on the Cell Plan? I can't find the name of the company anywhere....

Only that the cellplan costs £170 a year and £50 of this will go towards Reinsurance costs. They say it is a market leading Reinsurer but if you tell me the name I can be the judge of that.

Also if we knew who it was it would be a big selling point for the company.

I like the company although the share price has taken a little knock last 6 weeks?

Cashflow issues?

[balance1] 02/3/2018 07:38

The licence to open their Manchester cell bank at last means WDC can get into serious revenue.

[littlealbatross2] 27/2/2018 14:25

Thanks Smart. An interesting review.

[smartmoney100] 27/2/2018 13:57

Podcast featuring WDC from 24m30 : hxxps://www.voxmarkets.co.uk/blogs/versarien-vrs-connemara-mining-con-widecell-group-wdc-alan-green-phe-fbdk-cmbn/

[rampair] 17/1/2018 23:27

Let’s hope we are on the move a bit! It’s sat still for quite a while. Onwards and upwards.
(Please!)

R.